Clinical trial
YSPSL for Prevention of Delayed Graft Function Part B
NCT00298168 · Y's Therapeutics, Inc., Industry · Completed
Key facts
| NCT number | NCT00298168 |
|---|---|
| Title | YSPSL for Prevention of Delayed Graft Function Part B |
| Official title | Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Efficacy of YSPSL for Prevention of Delayed Graft Function in Patients Undergoing Cadaveric Kidney Transplantation |
| Lead sponsor | Y's Therapeutics, Inc., Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Diseases |
| Intervention type | Drug |
| Interventions | YSPSL, placebo |
| Enrollment | 60 |
| Start date | May 1, 2006 |
| Primary completion | Sep 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Mar 1, 2006 |
| Last update posted | Jan 29, 2008 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: